Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer

被引:7
作者
Adamovic, Tatjana [1 ]
Hamta, Ahmad [2 ]
Roshani, Leyla [2 ]
Lu, Xuchun [2 ]
Rohme, Dan [2 ]
Helou, Khalil [3 ]
Klinga-Levan, Karin [4 ]
Levan, Goeran [2 ]
机构
[1] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA
[2] Univ Gothenburg, CMB Genet, Gothenburg, Sweden
[3] Univ Gothenburg, Dept Oncol, Gothenburg, Sweden
[4] Univ Skovde, Sch Life Sci, Skovde, Sweden
关键词
D O I
10.1016/j.cancergencyto.2008.02.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The inbred BDII rat is a valuable experimental model for the genetic analysis of hormone-dependent endometrial adenocarcinoma (EAC). One common aberration detected previously by comparative genomic hybridization in rat EAC is loss affecting mostly the middle part of rat chromosome 5 (RNO5). First, we applied an RNO5-specific painting probe and four region-specific gene probes onto tumor cell metaphases from 21 EACs, and found that rearrangements involving RNO5 were common. The copy numbers of loci situated on RNO5 were found to be reduced, particularly for the CDKN2A/2B locus. Second, polymerase chain reaction analysis was performed with 22 genes and markers and homozygous deletions of the CDKN2A exon 1 beta and CDKN2B genes were detected in 13 EACs (62%) and of CDKN2A exon la in 12 EACs (57%) Third, the occurrence of allelic imbalance in RNO5 was analyzed using 39 microsatellite markers covering the entire chromosome and frequent loss of heterozygosity was detected. Even more intriguing was the repeated finding of allele switching in a narrow region of 7 Mb across the CDKN2A/2B locus. We conclude that genetic events affecting the middle part of RNO5 (including bands 5q31 similar to q33 and the CDKN2A locus) contribute to the development of EAC in rat, with the CDKN2A locus having a primary role. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:9 / 21
页数:13
相关论文
共 49 条
[1]   RATES OF P16(MTS1) MUTATIONS IN PRIMARY TUMORS WITH 9P LOSS [J].
CAIRNS, P ;
MAO, L ;
MERLO, A ;
LEE, DJ ;
SCHWAB, D ;
EBY, Y ;
TOKINO, K ;
VANDERRIET, P ;
BLAUGRUND, JE ;
SIDRANSKY, D .
SCIENCE, 1994, 265 (5170) :415-416
[2]   FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS [J].
CAIRNS, P ;
POLASCIK, TJ ;
EBY, Y ;
TOKINO, K ;
CALIFANO, J ;
MERLO, A ;
MAO, L ;
HERATH, J ;
JENKINS, R ;
WESTRA, W ;
RUTTER, JL ;
BUCKLER, A ;
GABRIELSON, E ;
TOCKMAN, M ;
CHO, KR ;
HEDRICK, L ;
BOVA, GS ;
ISAACS, W ;
KOCH, W ;
SCHWAB, D ;
SIDRANSKY, D .
NATURE GENETICS, 1995, 11 (02) :210-212
[3]  
Cavanagh, 1999, Cancer Control, V6, P354
[4]  
Christopher SA, 2002, CANCER RES, V62, P6639
[5]  
DEERBERG F, 1987, J NATL CANCER I, V78, P1245
[6]  
Fuxe J, 2000, CELL GROWTH DIFFER, V11, P373
[7]   Modelling the molecular circuitry of cancer [J].
Hahn, WC ;
Weinberg, RA .
NATURE REVIEWS CANCER, 2002, 2 (05) :331-341
[8]   Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization [J].
Hamta, A ;
Adamovic, T ;
Heloua, K ;
Levan, G .
CANCER GENETICS AND CYTOGENETICS, 2005, 159 (02) :123-128
[9]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[10]   Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization [J].
Helou, K ;
Walentinsson, A ;
Beckmann, B ;
Johansson, Å ;
Hedrich, HJ ;
Szpirer, C ;
Klinga-Levan, K ;
Levan, G .
CANCER GENETICS AND CYTOGENETICS, 2001, 127 (02) :118-127